SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Alexion Pharmaceuticals Inc. Release: New Data Highlighting Long-Term Efficacy and Safety Outcomes of PNH Patients Treated With Soliris® Reported at American Society of Hematology Annual Meeting